ORCHPHARMANSEOrchid Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 10 Jul, 2026 · 19:32 IST

Dhanuka Laboratories amalgamation with Orchid Pharma now effective

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹1008.45
prior close
₹1009.05
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.0% vs market
Pharmaceuticals peers, median of 167sector+0.1%+0.1% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.8
15m
-0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2+0.1+0.0+0.1+0.1
Next day
+4.9-0.9+5.8-0.0+5.0
2d
+9.2-0.2+9.5+0.0+9.2
3d
+6.8-0.7+7.5-0.1+6.9
4d
+2.9-1.8+4.7-1.0+4.0
5d
+3.8-1.2+5.0-0.5+4.3
1w
-0.8-2.0+1.2-1.7+0.8
15d
-2.6+0.0-2.7-1.8-0.8
1m
+3.0+2.5+0.6-0.7+3.8
2m
-2.1+1.1-3.2-0.2-1.9
3m
-4.9+1.2-6.1-2.3-2.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT Chennai has sanctioned the amalgamation of Dhanuka Laboratories Limited into Orchid Pharma Limited. The scheme became effective on July 10, 2026, after the certified copy of the NCLT order was filed with the Registrar of Companies, Chennai. The appointed date is April 1, 2024. Dhanuka Laboratories now stands amalgamated into Orchid Pharma and is dissolved without winding up.

Likely market impact

Dhanuka Laboratories is now merged into Orchid Pharma with the appointed date set at April 1, 2024; its assets and liabilities transfer to Orchid Pharma.